Genetic test helps predict which children with kidney disease will respond to standard therapy

Among children with sporadic nephrotic syndrome, genetic mutations in the kidney's filtration barrier were frequently linked with a lack of response to immunosuppressive treatments, researchers report. The genetic test was even more predictive than a kidney biopsy for identifying children who would not benefit from immunosuppressive therapies.